Literature DB >> 1954183

Multicenter phase II trial of the single agent fotemustine in patients with advanced malignant melanoma.

F Calabresi1, M Aapro, D Becquart, L Dirix, J Wils, A Ardizzoni, B Gerard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1954183     DOI： 10.1093/oxfordjournals.annonc.a057960

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

Review 1.  Management of melanoma brain metastases.

Authors:  Mary Frances McAleer; Dae W Kim; Van A Trinh; Wen-Jen Hwu
Journal:  Melanoma Manag       Date:  2015-08-10

2.  Phase II trial of fotemustine in patients with metastatic malignant melanoma.

Authors:  C I Falkson; G Falkson; H C Falkson
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

Review 3.  The history and future of chemotherapy for melanoma.

Authors:  Arvin S Yang; Paul B Chapman
Journal:  Hematol Oncol Clin North Am       Date:  2009-06       Impact factor: 3.722

Review 4.  Metastatic melanoma - a review of current and future drugs.

Authors:  Tiago Rodrigues Velho
Journal:  Drugs Context       Date:  2012-11-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.